Who is sponsoring NCT05050851?

NCT05050851 is sponsored by Assiut University.

What drugs are being tested in NCT05050851?

Interventions in NCT05050851: Measurement of nutritional parameters in children with pneumonia.

What condition does NCT05050851 study?

NCT05050851 studies Hypoalbuminemia, Stunted Growth, Anemia, Iron Deficiency.

Is NCT05050851 still recruiting?

NCT05050851 is currently status unknown. Last updated 21 September 2021.

Last reviewed 2021-09-21 · How we verify

NCT05050851

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Nutritional Parameters and Other Risk Factors Affecting Severity of Pneumonia in Children Under Five Years in Upper Egypt

Status unknown Last updated 21 September 2021

What this trial tests

trial testing Measurement of nutritional parameters in children with pneumonia in Hypoalbuminemia in 30 participants. Status unknown.

Timeline

30 September 2021

Primary endpoint
30 April 2022

30 October 2022

Quick facts

Lead sponsor	Assiut University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	30
Start date	30 September 2021
Primary completion	30 April 2022
Estimated completion	30 October 2022

Drugs / interventions tested

Measurement of nutritional parameters in children with pneumonia

Conditions studied

Hypoalbuminemia — all drugs for Hypoalbuminemia →
Stunted Growth — all drugs for Stunted Growth →
Anemia, Iron Deficiency — all drugs for Anemia, Iron Deficiency →

Sponsor

Assiut University

Who can join

Adults 1 Month to 60 Months, any sex, with Hypoalbuminemia or Stunted Growth. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Decrease mortality rate resulting from pneumonia

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Hypoalbuminemia

Currently open trials in the same condition.

NCT07186478 — I-FALMIN Albumin Supplement for Patients With Pulmonary Tuberculosis · NA · active not recruiting
NCT05797649 — Comparing the Diagnostic Sensitivity and Specificity of Pleural Fluid N-Terminal Pro B-type Natriuretic Peptide (NT-proB · recruiting

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05050851 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 21 September 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05050851.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing